Seven Eight Capital’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,546
| Closed | -$948K | – | 58 |
|
|
2024
Q3 | $948K | Buy |
+10,546
| New | +$948K | 0.09% | 414 |
|
|
2023
Q2 | – | Sell |
-3,819
| Closed | -$236K | – | 493 |
|
|
2023
Q1 | $236K | Sell |
3,819
-9,071
| -70% | -$559K | 0.05% | 373 |
|
|
2022
Q4 | $994K | Buy |
12,890
+6,225
| +93% | +$480K | 0.26% | 126 |
|
|
2022
Q3 | $297K | Buy |
+6,665
| New | +$297K | 0.06% | 382 |
|
|
2022
Q1 | – | Sell |
-8,384
| Closed | -$317K | – | 522 |
|
|
2021
Q4 | $317K | Sell |
8,384
-18,816
| -69% | -$711K | 0.06% | 355 |
|
|
2021
Q3 | $897K | Buy |
+27,200
| New | +$897K | 0.09% | 330 |
|
|
2019
Q3 | – | Sell |
-8,818
| Closed | -$227K | – | 590 |
|
|
2019
Q2 | $227K | Buy |
+8,818
| New | +$227K | 0.01% | 548 |
|